IL-UNITAS-GLOBAL
22.2.2021 14:03:13 CET | Business Wire | Press release
Unitas Global announces the availability of Unitas Reach™ , the first global software defined network (SDN) to offer automated ubiquitous edge access to any cloud location. Enterprises are finding that current networks are a bottleneck to the adoption of new technologies and capabilities – these problems have not been resolved, until now. Unitas Reach™ is the industry's first purpose-built network connecting cloud providers, carrier-neutral data centers, SaaS applications, and edge access networks to form a multi-service global interconnection fabric.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210222005156/en/
"Organizations today need flexible, proven, and secure infrastructure to run their enterprise applications and multi-cloud solutions," shares Patrick Shutt, CEO of Unitas Global. "With Unitas Reach™, our clients achieve cost-optimized network connectivity with the agility needed to scale quickly and support the growing demands of applications on network architectures, performance, and costs."
Unitas Reach™ is built to provide connectivity options that different modern cloud services require with simple integration to traditional enterprise networks. With its presence on six continents, Unitas Reach™ provides redundant and diverse Internet, IP, Ethernet, and Wave access to distributed applications across any cloud, hybrid-cloud, multi-cloud, or private cloud destination. Strategic interconnections with hundreds of other networks and fiber access providers further extends the network access to the edge, including over 900 carrier neutral data centers and 30 million enterprise locations in over 85 countries. Sophisticated automation, monitoring, and orchestration to the edge make the entire interconnect fabric unmatched in enabling complete flexibility in service creation and scaling capacity as enterprise networking needs change.
"We designed Unitas Reach™ in response to the dynamic networking requirements that today's businesses require and have yet to experience," comments Grant Kirkwood, Founder and CTO of Unitas Global. "Providers and enterprises can easily add connectivity to dynamically support their ever changing network strategies, and customize capabilities to their unique set of service delivery, operations, access and configuration requirements.”
Unitas' edge to everywhere connectivity solutions offer providers and enterprises with automated:
- Cloud On-ramps™ for multi-cloud delivery
- High performance managed Internet
- Direct connectivity to and between multi-cloud platforms
- Agile and scalable WAN solutions
Unitas Reach™ provides the greatest choice and ease of use for provisioning enterprises with connectivity that delivers agile, cost-effective, low-latency connections to optimize application performance. Unitas Global solves the enterprise challenge by going to market with MSPs, hyperscalers, and data centers who are able to establish an on-net point of presence with Unitas Reach™ to expand their network coverage, scale services everywhere, and locate applications as close to customers as possible to improve performance and optimize costs.
Learn more about Unitas Reach™ and its edge to everywhere connectivity solution.
About Unitas Global
Unitas Global is a global managed network service provider offering automated ubiquitous edge access to any cloud, everywhere. The company provides the most agile connected multi-cloud environments that are easy-to-consume, fully managed, and backed by a promise to deliver the best application performance. Connect with Unitas at LinkedIn , Twitter , and its Blog .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210222005156/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer1.9.2026 08:30:00 CEST | Press release
Approval based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s Enhertu plus pertuzumab reduced the risk of disease progression or death by 44% versus THP with a median progression-free survival exceeding three years Second approval for Enhertu in the EU in two months Enhertu® (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the European Union (EU) for the first-line treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results fro
Paris Hilton Returns as the Face of KARL LAGERFELD as NOT-KARL Debuts for Fall–Winter 20261.9.2026 08:30:00 CEST | Press release
Following the success of the Maison's Fall-Winter 2025 and Spring-Summer 2026 campaigns, KARL LAGERFELD is delighted to announce the extension of its relationship with global entrepreneur, media personality and cultural icon Paris Hilton, continuing a partnership that has resonated with audiences around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831566835/en/ KARL LAGERFELD - Paris Hilton ©Matt Easton As the face of the Maison through Fall-Winter 2026 and Spring-Summer 2027, Paris Hilton returns for the next chapter of KARL LAGERFELD's From Paris With Love story, continuing to bring her signature confidence, wit and individuality. Photographed for the first time by Matt Easton, the Fall-Winter 2026 campaign introduces a new dimension to the narrative while remaining true to the House's established codes. At the heart of the Fall-Winter 2026 story, two masters of self-reinvention meet. Making his debut is NO
Flashnet Partners with Netmore in Strategic Global Partnership for Smart Street Lighting1.9.2026 08:00:00 CEST | Press release
Collaboration combines carrier-grade LoRaWAN® connectivity with award-winning smart street lighting technology to accelerate smart city transformation Netmore Group, the leading network operator and platform provider for Massive IoT, today announced that Flashnet, a Lucy Group company and global leader in intelligent street lighting solutions, has joined Netmore's Pulse Partner Program. The partnership marks another important milestone in Netmore's growing ecosystem, combining best-in-class connectivity with proven smart infrastructure solutions to accelerate the digital transformation of cities and utilities around the world. Driven by rapid urbanisation, government sustainability mandates, and the accelerating rollout of smart city programs worldwide, smart street lighting is increasingly recognized as the entry point for smart city transformation and one of the fastest-growing segments of the global IoT infrastructure market. As municipalities and utilities continue to modernize cri
Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays1.9.2026 07:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Health Canada has issued Class II Medical Device Licenses (MDL) for the Lumipulse G NfL Blood and the Lumipulse G pTau 217 Plasma assay for use on the fully automated LUMIPULSE® G immunoassay platform in the Canadian market. "The approval of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for clinical use in Canada marks another important step in our mission to expand access to reliable and clinically meaningful blood-based biomarkers for clinicians and patients worldwide," said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “As a pioneer in neurological diagnostics, Fujirebio remains committed to advancing patient care through innovative, fully automated testing solutions." These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions designed to inform clinical decision-making across the
Helical Fusion Named a Final Candidate for Japan’s METI Fusion Power Demonstration Program1.9.2026 04:00:00 CEST | Press release
Milestone-based government program supports multiple fusion approaches toward power demonstration and commercialization Helical Fusion Co., Ltd., a fusion energy company developing a Helical Stellarator toward commercially viable fusion power, has been named a final candidate for Japan’s Ministry of Economy, Trade and Industry (METI) program supporting the demonstration of fusion power generation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260831991676/en/ Image of Helix HARUKA, Helical Fusion’s Integrated Demo Device(left), and Helix KANATA, Helical Fusion’s Fusion Pilot Plant(right) The program is designed to accelerate fusion power demonstration in the 2030s under Japan’s national energy and fusion strategies. It supports private-sector technology development across multiple fusion approaches, including tokamak, stellarator and laser fusion, with approximately JPY 60 billion in total government support anticipated ove
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom